Plato Investment Management Ltd Invests $10.01 Million in Procter & Gamble Company (The) $PG

Plato Investment Management Ltd purchased a new stake in Procter & Gamble Company (The) (NYSE:PGFree Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 68,665 shares of the company’s stock, valued at approximately $10,010,000.

Other institutional investors have also recently modified their holdings of the company. Cibc World Market Inc. lifted its stake in shares of Procter & Gamble by 40.6% in the fourth quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock valued at $73,351,000 after purchasing an additional 147,701 shares during the period. World Investment Advisors grew its position in Procter & Gamble by 15.9% during the fourth quarter. World Investment Advisors now owns 105,915 shares of the company’s stock worth $15,179,000 after buying an additional 14,492 shares during the period. Resources Management Corp CT ADV increased its holdings in Procter & Gamble by 41.8% in the fourth quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock valued at $11,681,000 after buying an additional 24,010 shares in the last quarter. Indivisible Partners purchased a new position in Procter & Gamble in the fourth quarter valued at about $2,120,000. Finally, Rokos Capital Management LLP acquired a new stake in shares of Procter & Gamble during the 1st quarter valued at approximately $29,914,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $144.77 on Friday. The company has a market cap of $336.51 billion, a P/E ratio of 21.87, a P/E/G ratio of 4.40 and a beta of 0.39. The business has a fifty day simple moving average of $147.73 and a 200-day simple moving average of $148.69. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. During the same period in the prior year, the business posted $1.48 earnings per share. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Friday, July 24th. Procter & Gamble’s dividend payout ratio is presently 65.71%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Wednesday, June 24th. Sanford C. Bernstein assumed coverage on Procter & Gamble in a research report on Thursday, June 11th. They set a “market perform” rating and a $156.00 target price on the stock. BMO Capital Markets upped their target price on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, June 29th. HSBC restated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Finally, UBS Group lifted their price target on Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a research note on Monday, April 27th. Thirteen research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $161.52.

View Our Latest Research Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.